83.90EUR-0.24%Mkt Cap: 873.22M $P/E: 38.141d ago
Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internati…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap873.22M $
Enterprise Value864.71M $
Revenue (TTM)151.02M $
Gross Profit111.81M $
Net Income (TTM)21.74M $
Revenue/Share15.81 USD
Last Price83.90 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees140
CountryIT
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINIT0005274094
Valuation
P/E (Trailing)38.14
P/E (Forward)27.39
PEG—
EV/EBITDA23.94
EV/Revenue5.73
P/S5.78
P/B10.81
EPS (TTM)2.20
EPS (Forward)3.06
52W Range
38.7579% of range95.90
52W High95.90 EUR
52W Low38.75 EUR
Profitability
Gross Margin77.38%
Oper. Margin15.62%
EBITDA Margin23.92%
Profit Margin15.05%
ROE28.03%
ROA15.97%
Growth
Revenue Growth25.60%
Earnings Growth44.00%
Cash Flow & Leverage
Operating CF21.26M $
CapEx (TTM)3.41M $
FCF Margin10.55%
FCF Yield1.82%
Net Debt-10.77M $
Net Debt/EBITDA-0.30
Balance Sheet
Debt/Equity0.29
Current Ratio2.38
Quick Ratio1.84
Book Value/Sh7.758 EUR
Cash/Share3.021 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate1.200 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)81.33 EUR
Upside (mean)-3.1%
Target Range76.00 EUR – 86.00 EUR
€76.00-3.1% to mean€86.00
# Analysts3
Ownership
Shares Out.9.58M
Float3.28M
Insiders65.02%
Institutions15.62%
Technical
SMA 5088.11 (-4.8%)
SMA 20068.38 (+22.7%)
Beta0.19
S&P 52W Chg20.25%
Avg Vol (30d)11.39K
Avg Vol (10d)9.56K
Technical Indicators
RSI (14)35.7
MACD-0.6571
MACD Signal-0.0195
MACD Hist.-0.6376
BB Upper91.31 EUR
BB Middle87.86 EUR
BB Lower84.41 EUR
BB Width7.86%
ATR (14)2.569 EUR
Vol Ratio (20d)1.03x